AI-Designed Drug Experiment Spurs Investment in Life Sciences

• Researchers used Anthropic PBC’s Claude Science to design a drug.
• This experiment has led to a new investment thesis in life sciences.
• Citrini Research highlights the potential of AI in drug discovery.
• Life sciences companies may benefit from increased AI-fueled research.
• Artificial intelligence is being touted for its potential to revolutionize drug development.